CJC-1295 (with DAC) 5 mg
Advanced Long-Acting GHRH Research
CJC-1295 (DAC) incorporates a Drug Affinity Complex (DAC) that extends its half-life by enabling reversible binding to serum albumin. This prolonged activity distinguishes it from CJC-1295 (No DAC), making it a valuable research tool for studying sustained stimulation of the growth hormone/IGF-1 axis, endocrine physiology, metabolism, tissue regeneration, and healthy aging models.
Manufactured to rigorous quality standards and supported by comprehensive third-party analytical testing, our CJC-1295 (DAC) delivers exceptional purity, identity, and batch-to-batch consistency for reliable laboratory research.
Key Research Areas
- Growth Hormone-Releasing Hormone (GHRH) signaling
- Sustained growth hormone (GH) secretion
- Growth hormone (GH) and IGF-1 axis research
- Endocrine physiology
- Tissue repair and regeneration models
- Metabolic and body composition research
- Healthy aging research
Product Features
- 5 mg CJC-1295 (DAC) per vial
- Long-acting GHRH analog with Drug Affinity Complex (DAC)
- High-purity lyophilized peptide
- Manufactured under strict quality standards
- Third-party tested for identity and purity
- Certificate of Analysis (COA) available for every batch
- Intended exclusively for laboratory research use
